Monday, April 27, 2015 9:12:28 AM
Apr 27, 2015
OTC Disclosure & News Service
-
WHIPPANY, N.J., April 27, 2015 (GLOBE NEWSWIRE) -- Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#:A1J3DK), is pleased to announce that as of today and more than a week ahead of schedule, the company has completely repaid the total of its obligations on its Convertible Promissory Note to Eastmore Capital LLC. Pazoo announced on April 15 its intentions to pay off Eastmore Capital within the next few weeks. Pazoo made good today on their intentions.
Pazoo is in a very aggressive expansion and growth mode and has plans to accelerate the expansion plans moving forward. In the future, Pazoo may need to finance debt to facilitate and fund this rapid expansion. However, management is very well aware of the effects of dilution and, as demonstrated in our debt paying actions, strives to protect its shareholders. Pazoo firmly believes share valuations will reflect a much stronger fundamental valuation realized through organic growth, potential acquisitions, current site revenues and new possibilities in the future.
Pazoo CEO David Cunic commented, "Raising money to fund expansion and growth is great when it is accretive. We have pared our overhead as low as possible to make sure every dollar is directly invested into the expansion and growth of Pazoo and related subsidiaries. Many big opportunities lay ahead of us and we plan on delivering on everyone of them."
About Pazoo, Inc.:
Pazoo, Inc. is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo is licensed to test cannabis in Nevada, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com, and features industry experts from both the health and wellness arena and the pet industry.
www.otcmarkets.com/stock/PZOO/news/Pazoo--Inc--Confirms-Paying-Off-Note-to-Eastmore-Capital-LLC--More-Than-a-Week-Early-and-Plans-to-Retire-the-Few-Notes-Remaining-Through-the-Summer?id=102904&b=y
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM